The spread of the SARS-CoV-2 virus and the ongoing epidemiological measures may affect the increase in the incidence of tuberculosis, which is associated with objective difficulties in detecting this infection against the background of COVID-19 and the development of complications after the disease.

Tuberculosis is an infectious disease, the problem of which is still relevant all over the world. The possibility of combining these infectious diseases can lead to an increase in mortality from tuberculosis against the background of an objective decrease in the number of cases, which is associated with difficulties in the diagnosis and treatment of tuberculosis infection against the background of COVID-19.

tuberculosis, diagnosis, new coronavirus infection, COVID-19, SARS-CoV-2, pandemic.

Zabozlaev V.G., Kravchenko V.V., Gallyamova A.R., Letunovsky N.N. Pathological lung anatomy in new coronavirus infection (COVID-19). Preliminary analysis of autopsy studies. Clinical practice. 2020;11(2):21-37.

Melgina E.V., Gorelov A.V., Muzika A.D. Clinical manifestations of COVID-19 infection in children of various age groups Literature review by early April 2020 Issues of practical pediatrics. 2020;15(2):7-20.

Starshinova A.A., Kushnareva E.A., Malkova A.M., Dovga-luk.F., Kudlay D.A. New coronavirus infection: clinical features, possibilities of diagnosis, treatment and prevention of infection in adults and children Issues of modern pediatrics. 2020;19(2):123-31.

Hogan A.B., Jewell B.L., Sherrard-Smith E., Vesga J.F., Watson O.J., Whittaker S. et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low- and middle-income countries: a model study. LancetGlobHealth. 2020;8(9): e1132-41.

Colaneri M., Bololo L., Valsecchi P., Sacchi P., Zuccaro V., Brantolino F. and others. Tocilizumab for the treatment of patients with severe COVID-19: Preliminary results from the SMAtteo Covid19 Registry (SMACORE). A microorganism. 2020;8(5):695.